Trials / Active Not Recruiting
Active Not RecruitingNCT04541693
REDAPT Revision Hip System With RSA
Early Stability Assessment of the REDAPT Revision Hip System With Radiostereometric Analysis
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Orthopaedic Innovation Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The principal objectives of the study are to evaluate early and mid-term fixation of the REDAPT revision hip stem and acetabular cup as measured by stem subsidence and proximal cup migration at 2 and 5 years post-surgery through model-based RSA. Secondary objectives include; evaluate the progression of migration between 1 and 2 years and between 2 and 5 years, assess pre- to post-surgery patient improvement in function and health status, evaluate femoral and acetabular radiolucency at 2 and 5 years, and assess patterns of stem migrate on for different revision scenarios (preservation of the trochanters and extended trochanteric osteotomy).
Detailed description
This is a prospective, single arm, consecutive series study of patients undergoing revision hip arthroplasty. Patients will be grouped based on the revision implants they receive during surgery. Patients who receive a full hip revision (stem and cup), will be counted in both study groups. The two study groups are: 1. femoral stem revision (n=30 hips) 2. acetabular cup revision (n=22 hips)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Full revision | Both cup and stem require revision |
| DEVICE | Cup revision | Only the cup requires revision |
| DEVICE | Stem revision | Only the stem requires revision |
Timeline
- Start date
- 2019-01-15
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
- First posted
- 2020-09-09
- Last updated
- 2024-11-15
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04541693. Inclusion in this directory is not an endorsement.